Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes

Markers of myocardial damage, inflammation, and homocysteine analyzed separately provide prognostic information. The number of elevated biomarkers is an independent risk predictor of major events.